Follow
Buonomo Antonio
Buonomo Antonio
Professore di Microelettronica
Verified email at unina2.it
Title
Cited by
Cited by
Year
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ...
Journal of translational medicine 18 (1), 405, 2020
1452020
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
M Bartoletti, M Giannella, R Lewis, P Caraceni, S Tedeschi, M Paul, ...
Clinical Microbiology and Infection 24 (5), 546. e1-546. e8, 2018
942018
The periodic solution of van der Pol's equation
A Buonomo
SIAM Journal on Applied Mathematics 59 (1), 156-171, 1998
831998
Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: prevalence, predictive factors, therapeutic outcome
L Santarpia, A Buonomo, MC Pagano, L Alfonsi, M Foggia, M Mottola, ...
Clinical nutrition 35 (6), 1394-1398, 2016
762016
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C
I Gentile, AE Maraolo, AR Buonomo, E Zappulo, G Borgia
Expert Opinion on Drug Discovery 10 (12), 1363-1377, 2015
682015
Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
I Gentile, AR Buonomo, F Borgia, G Castaldo, G Borgia
Expert opinion on investigational drugs 23 (4), 561-571, 2014
672014
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?
C Nardelli, I Gentile, M Setaro, C Di Domenico, B Pinchera, AR Buonomo, ...
Frontiers in cellular and infection microbiology 11, 625581, 2021
652021
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver …
I Gentile, R Scotto, C Coppola, L Staiano, DC Amoruso, T De Simone, ...
Hepatology international 13, 66-74, 2019
652019
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis
AR Buonomo, E Zappulo, G Viceconte, R Scotto, G Borgia, I Gentile
Expert Opinion on Drug Safety 17 (7), 709-717, 2018
652018
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
N Coppola, I Gentile, G Pasquale, AR Buonomo, N Capoluongo, ...
Annals of hepatology 13 (1), 20-26, 2014
642014
Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A
I Gentile, F Borgia, N Coppola, AR Buonomo, G Castaldo, G Borgia
Current medicinal chemistry 21 (12), 1391-1404, 2014
632014
Asymptotic formulas in nearly sinusoidal nonlinear oscillators
A Buonomo, C Di Bello
IEEE Transactions on Circuits and Systems I: Fundamental Theory and …, 1996
611996
Modelling and analysis of differential VCOs
A Buonomo, AL Schiavo
International Journal of Circuit Theory and Applications 32 (3), 117-131, 2004
602004
Analysis of emitter (source)-coupled multivibrators
A Buonomo, AL Schiavo
IEEE Transactions on Circuits and Systems I: Regular Papers 53 (6), 1193-1202, 2006
582006
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
I Gentile, AR Buonomo, E Zappulo, G Borgia
Expert review of anti-infective therapy 12 (7), 763-773, 2014
552014
MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection
I Gentile, AR Buonomo, F Borgia, E Zappulo, G Castaldo, G Borgia
Expert opinion on investigational drugs 23 (5), 719-728, 2014
552014
Nirmatrelvir/ritonavir and molnupiravir in the treatment of mild/moderate COVID-19: results of a real-life study
I Gentile, R Scotto, N Schiano Moriello, B Pinchera, R Villari, E Trucillo, ...
Vaccines 10 (10), 1731, 2022
502022
Perturbation analysis of nonlinear distortion in analog integrated circuits
A Buonomo, AL Schiavo
IEEE Transactions on Circuits and Systems I: Regular Papers 52 (8), 1620-1631, 2005
502005
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus
I Gentile, E Zappulo, AR Buonomo, G Borgia
Expert review of anti-infective therapy 12 (7), 775-782, 2014
492014
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
I Gentile, AR Buonomo, E Zappulo, G Minei, F Morisco, F Borrelli, ...
Therapeutics and clinical risk management, 493-504, 2014
462014
The system can't perform the operation now. Try again later.
Articles 1–20